Breast Cancer Drug Enhertu Approved for Use in England's NHS
Enhertu, a breast cancer treatment, has received approval for use within England's National Health Service. Clinical trials indicate the drug provides an average of seven additional months of life for patients. This approval follows its availability in Scotland for more than two years.
Advertisement
London, England — The National Health Service (NHS) in England has approved Enhertu, a medication for breast cancer patients.
Patients taking Enhertu have experienced an average of seven additional months of life, according to clinical data. The drug has been accessible to patients in Scotland for over two years.
This approval integrates Enhertu into England's NHS treatment protocols, expanding options for eligible breast cancer patients.
Related Topics
Article Ratings
How do you feel about this story?
National Desk
Sign in to follow this author from their profile.
Discussion (0)
Join the Conversation
Join the conversation
Sign in to share your thoughts, reply to readers, and like comments.
No comments yet. Be the first to comment!